Order Article Reprints

Camorani S, Tortorella S, Agnello L, Spanu C, d’Argenio A, Nilo R, Zannetti A, Locatelli E, Fedele M, Comes Franchini M, et al. Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells. Pharmaceutics. 2022; 14(10):2225. https://doi.org/10.3390/pharmaceutics14102225

Camorani, Simona, Silvia Tortorella, Lisa Agnello, Chiara Spanu, Annachiara d’Argenio, Roberto Nilo, Antonella Zannetti, Erica Locatelli, Monica Fedele, Mauro Comes Franchini, and et al. 2022. "Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells" Pharmaceutics 14, no. 10: 2225. https://doi.org/10.3390/pharmaceutics14102225

Camorani, S., Tortorella, S., Agnello, L., Spanu, C., d’Argenio, A., Nilo, R., Zannetti, A., Locatelli, E., Fedele, M., Comes Franchini, M., & Cerchia, L. (2022). Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells. Pharmaceutics, 14(10), 2225. https://doi.org/10.3390/pharmaceutics14102225